A detailed history of Sit Investment Associates Inc transactions in Eli Lilly & CO stock. As of the latest transaction made, Sit Investment Associates Inc holds 26,200 shares of LLY stock, worth $20.8 Million. This represents 0.52% of its overall portfolio holdings.

Number of Shares
26,200
Previous 12,418 110.98%
Holding current value
$20.8 Million
Previous $11.2 Million 106.46%
% of portfolio
0.52%
Previous 0.26%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$772.14 - $960.02 $10.6 Million - $13.2 Million
13,782 Added 110.98%
26,200 $23.2 Million
Q2 2024

Aug 14, 2024

BUY
$724.87 - $909.04 $9 Million - $11.3 Million
12,410 Added 155125.0%
12,418 $11.2 Million
Q4 2023

Feb 13, 2024

BUY
$525.19 - $619.13 $4,201 - $4,953
8 New
8 $1,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $756B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Sit Investment Associates Inc Portfolio

Follow Sit Investment Associates Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sit Investment Associates Inc, based on Form 13F filings with the SEC.

News

Stay updated on Sit Investment Associates Inc with notifications on news.